The beginning of embryonic stem cell (ESC) research can be pegged to 1981 when the first reports of the derivation of mouse embryonic stem cells (mESC) were made.1,2 Scientists subsequently showed ...
Cellular immunotherapy—for example, Chimeric Antigen Receptor (CAR)-T cell therapy—has shown great efficacy in treating various hematologic malignancies. CAR-T therapy has undergone notable changes, ...